Introduction: Randomized controlled trials (RCTs) of testosterone therapy (TTh) for late-onset hypogonadism are systematically reviewed and a meta-analysis to assess the efficacy of TTh in improving erectile function is performed. Methods: The PubMed, Cochrane Library, and Web of Science databases were searched to identify RCTs published from 2007. RCTs that assessed erectile function using the erectile function domain of the International Index of Erectile Function (IIEF-EFD) were included in the meta-analysis. Results: The systematic review included 18 RCTs and the meta-analysis included 6 studies that enrolled a total of 1,458 patients. The overall meta-analysis revealed that the IIEF-EFD score was significantly improved in the TTh group compared with the placebo group (mean difference 1.86; 95% confidence interval 1.01–2.72; p < 0.0001). Compared with patients receiving placebo, there was a significant improvement in the IIEF-EFD of patients who received TTh using testosterone gel, those who received TTh for over 30 weeks, and those without diabetes mellitus or metabolic syndrome. Conclusion: TTh achieved a significant improvement in the IIEF-EFD score of hypogonadal men compared with placebo, especially in those who received testosterone gel, were treated for over 30 weeks, and had no comorbidities.

1.
Wang
C
,
Nieschlag
E
,
Swerdloff
R
,
Behre
HM
,
Hellstrom
WJ
,
Gooren
LJ
,
Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations
.
Eur J Endocrinol
.
2008 Nov
;
159
(
5
):
507
14
. .
2.
Harman
SM
,
Metter
EJ
,
Tobin
JD
,
Pearson
J
,
Blackman
MR
.
Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore longitudinal study of aging
.
J Clin Endocrinol Metab
.
2001 Feb
;
86
(
2
):
724
31
. .
3.
Schubert
M
,
Jockenhövel
F
.
Late-onset hypogonadism in the aging male (LOH): definition, diagnostic and clinical aspects
.
J Endocrinol Invest
.
2005
;
28
(
3 Suppl l
):
23
7
.
4.
Corona
G
,
Isidori
AM
,
Aversa
A
,
Burnett
AL
,
Maggi
M
.
Endocrinologic control of men’s sexual desire and arousal/erection
.
J Sex Med
.
2016 Mar
;
13
(
3
):
317
37
. .
7.
Isidori
AM
,
Giannetta
E
,
Gianfrilli
D
,
Greco
EA
,
Bonifacio
V
,
Aversa
A
,
Effects of testosterone on sexual function in men: results of a meta-analysis
.
Clin Endocrinol
.
2005 Oct
;
63
(
4
):
381
94
. .
8.
Corona
G
,
Rastrelli
G
,
Morgentaler
A
,
Sforza
A
,
Mannucci
E
,
Maggi
M
.
Meta-analysis of results of testosterone therapy on sexual function based on international index of erectile function scores
.
Eur Urol
.
2017 Dec
;
72
(
6
):
1000
11
. .
9.
Moher
D
,
Liberati
A
,
Tetzlaff
J
,
Altman
DG
.
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
.
BMJ
.
2009 Aug 18
;
339
(
4
):
b2535w64
9
. .
10.
Higgins
JPT
.
Cochrane handbook for systematic reviews of interventions
.
2011
11.
Higgins
JP
,
Thompson
SG
.
Quantifying heterogeneity in a meta-analysis
.
Stat Med
.
2002 Jun 15
;
21
(
11
):
1539
58
. .
12.
Rosen
RC
,
Riley
A
,
Wagner
G
,
Osterloh
IH
,
Kirkpatrick
J
,
Mishra
A
.
The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction
.
Urology
.
1997 Jun
;
49
(
6
):
822
30
. .
13.
Chiang
HS
,
Cho
SL
,
Lin
YC
,
Hwang
TI
.
Testosterone gel monotherapy improves sexual function of hypogonadal men mainly through restoring erection: evaluation by IIEF score
.
Urology
.
2009 Apr
;
73
(
4
):
762
6
. .
14.
Amiaz
R
,
Pope
HG
 Jr
,
Mahne
T
,
Kelly
JF
,
Brennan
BP
,
Kanayama
G
,
Testosterone gel replacement improves sexual function in depressed men taking serotonergic antidepressants: a randomized, placebo-controlled clinical trial
.
J Sex Marital Ther
.
2011
;
37
(
4
):
243
54
. .
15.
Buvat
J
,
Montorsi
F
,
Maggi
M
,
Porst
H
,
Kaipia
A
,
Colson
MH
,
Hypogonadal men nonresponders to the PDE5 inhibitor tadalafil benefit from normalization of testosterone levels with a 1% hydroalcoholic testosterone gel in the treatment of erectile dysfunction (TADTEST study)
.
J Sex Med
.
2011 Jan
;
8
(
1
):
284
93
. .
16.
Jones
TH
,
Arver
S
,
Behre
HM
,
Buvat
J
,
Meuleman
E
,
Moncada
I
,
Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study)
.
Diabetes care
.
2011 Apr
;
34
(
4
):
828
37
. .
17.
Spitzer
M
,
Basaria
S
,
Travison
TG
,
Davda
MN
,
Paley
A
,
Cohen
B
,
Effect of testosterone replacement on response to sildenafil citrate in men with erectile dysfunction: a parallel, randomized trial
.
Ann Intern Med
.
2012 Nov 20
;
157
(
10
):
681
91
. .
18.
Basaria
S
,
Harman
SM
,
Travison
TG
,
Hodis
H
,
Tsitouras
P
,
Budoff
M
,
Effects of testosterone administration for 3 years on subclinical atherosclerosis progression in older men with low or low-normal testosterone levels: a randomized clinical trial
.
Jama
.
2015 Aug 11
;
314
(
6
):
570
81
. .
19.
Paduch
DA
,
Polzer
PK
,
Ni
X
,
Basaria
S
.
Testosterone replacement in androgen-deficient men with ejaculatory dysfunction: a randomized controlled trial
.
J Clin Endocrinol Metab
.
2015 Aug
;
100
(
8
):
2956
62
. .
20.
Brock
G
,
Heiselman
D
,
Maggi
M
,
Kim
SW
,
Rodríguez Vallejo
JM
,
Behre
HM
,
Effect of testosterone solution 2% on testosterone concentration, sex drive and energy in hypogonadal men: results of a placebo controlled study
.
J Urol
.
2016 Mar
;
195
(
3
):
699
705
. .
21.
Snyder
PJ
,
Bhasin
S
,
Cunningham
GR
,
Matsumoto
AM
,
Stephens-Shields
AJ
,
Cauley
JA
,
Effects of testosterone treatment in older men
.
N Engl J Med
.
2016 Feb 18
;
374
(
7
):
611
24
. .
22.
Yucel
C
,
Keskin
MZ
,
Peskircioglu
CL
.
The effect of transdermal testosterone administration on lower urinary tract symptoms and erectile dysfunction: a prospective, randomized, placebo-controlled trial
.
Curr Urol
.
2017 Nov
;
11
(
1
):
4
8
. .
23.
Aversa
A
,
Bruzziches
R
,
Francomano
D
,
Spera
G
,
Lenzi
A
.
Efficacy and safety of two different testosterone undecanoate formulations in hypogonadal men with metabolic syndrome
.
J Endocrinol Invest
.
2010 Dec
;
33
(
11
):
776
83
. .
24.
Giltay
EJ
,
Tishova
YA
,
Mskhalaya
GJ
,
Gooren
LJ
,
Saad
F
,
Kalinchenko
SY
.
Effects of testosterone supplementation on depressive symptoms and sexual dysfunction in hypogonadal men with the metabolic syndrome
.
J Sex Med
.
2010 Jul
;
7
(
7
):
2572
82
. .
25.
Gianatti
EJ
,
Dupuis
P
,
Hoermann
R
,
Strauss
BJ
,
Wentworth
JM
,
Zajac
JD
,
Effect of testosterone treatment on glucose metabolism in men with type 2 diabetes: a randomized controlled trial
.
Diabetes care
.
2014 Aug
;
37
(
8
):
2098
107
. .
26.
Hackett
G
,
Cole
N
,
Saghir
A
,
Jones
P
,
Strange
RC
,
Ramachandran
S
.
Testosterone replacement therapy: improved sexual desire and erectile function in men with type 2 diabetes following a 30-week randomized placebo-controlled study
.
Andrology
.
2017 Sep
;
5
(
5
):
905
13
. .
27.
Ng Tang Fui
M
,
Hoermann
R
,
Prendergast
LA
,
Zajac
JD
,
Grossmann
M
.
Symptomatic response to testosterone treatment in dieting obese men with low testosterone levels in a randomized, placebo-controlled clinical trial
.
Int J Obes
.
2017 Mar
;
41
(
3
):
420
6
. .
28.
Morales
A
,
Black
A
,
Emerson
L
,
Barkin
J
,
Kuzmarov
I
,
Day
A
.
Androgens and sexual function: a placebo-controlled, randomized, double-blind study of testosterone versus dehydroepiandrosterone in men with sexual dysfunction and androgen deficiency
.
Aging Male
.
2009 Dec
;
12
(
4
):
104
12
. .
29.
Konaka
H
,
Sugimoto
K
,
Orikasa
H
,
Iwamoto
T
,
Takamura
T
,
Takeda
Y
,
Effects of long-term androgen replacement therapy on the physical and mental statuses of aging males with late-onset hypogonadism: a multicenter randomized controlled trial in Japan (EARTH Study)
.
Asian J Androl
.
2016 Jan-Feb
;
18
(
1
):
25
34
. .
30.
Allan
CA
,
Forbes
EA
,
Strauss
BJ
,
McLachlan
RI
.
Testosterone therapy increases sexual desire in ageing men with low-normal testosterone levels and symptoms of androgen deficiency
.
Int J Impot Res
.
2008 Jul
;
20
(
4
):
396
401
. .
31.
Heinemann
LA
,
Saad
F
,
Zimmermann
T
,
Novak
A
,
Myon
E
,
Badia
X
,
The aging males’ symptoms (AMS) scale: update and compilation of international versions
.
Health Qual Life Outcomes
.
2003 May 1
;
1
:
15
. .
32.
Bhasin
S
,
Brito
JP
,
Cunningham
GR
,
Hayes
FJ
,
Hodis
HN
,
Matsumoto
AM
,
Testosterone therapy in men with hypogonadism: an endocrine society clinical practice guideline
.
J Clin Endocrinol Metab
.
2018 May 1
;
103
(
5
):
1715
44
. .
33.
Khera
M
,
Adaikan
G
,
Buvat
J
,
Carrier
S
,
El-Meliegy
A
,
Hatzimouratidis
K
,
Diagnosis and treatment of testosterone deficiency: recommendations from the fourth international consultation for sexual medicine (ICSM 2015)
.
J Sex Med
.
2016 Dec
;
13
(
12
):
1787
804
. .
34.
Hackett
G
,
Kirby
M
,
Edwards
D
,
Jones
TH
,
Wylie
K
,
Ossei-Gerning
N
,
British society for sexual medicine guidelines on adult testosterone deficiency, with statements for UK practice
.
J Sex Med
.
2017 Dec
;
14
(
12
):
1504
23
. .
35.
Grossmann
M
,
Matsumoto
AM
.
A perspective on middle-aged and older men with functional hypogonadism: focus on holistic management
.
J Clin Endocrinol Metab
.
2017 Mar 1
;
102
(
3
):
1067
75
. .
36.
Maseroli
E
,
Corona
G
,
Rastrelli
G
,
Lotti
F
,
Cipriani
S
,
Forti
G
,
Prevalence of endocrine and metabolic disorders in subjects with erectile dysfunction: a comparative study
.
J Sex Med
.
2015 Apr
;
12
(
4
):
956
65
. .
37.
Perheentupa
A
,
Huhtaniemi
I
.
Aging of the human ovary and testis
.
Mol Cell Endocrinol
.
2009 Feb 5
;
299
(
1
):
2
13
. .
38.
Corona
G
,
Vignozzi
L
,
Sforza
A
,
Mannucci
E
,
Maggi
M
.
Obesity and late-onset hypogonadism
.
Mol Cell Endocrinol
.
2015 Dec 15
;
418
(
Pt 2
):
120
33
. .
39.
Algeffari
M
,
Jayasena
CN
,
MacKeith
P
,
Thapar
A
,
Dhillo
WS
,
Oliver
N
.
Testosterone therapy for sexual dysfunction in men with Type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials
.
Diabet Med
.
2018 Feb
;
35
(
2
):
195
202
. .
40.
Zhu
J
,
Zhang
W
,
Ou
N
,
Song
Y
,
Kang
J
,
Liang
Z
,
Do testosterone supplements enhance response to phosphodiesterase 5 inhibitors in men with erectile dysfunction and hypogonadism: a systematic review and meta-analysis
.
Transl Androl Urol
.
2020 Apr
;
9
(
2
):
591
600
. .
41.
Rosen
RC
,
Allen
KR
,
Ni
X
,
Araujo
AB
.
Minimal clinically important differences in the erectile function domain of the international index of erectile function scale
.
Eur Urol
.
2011 Nov
;
60
(
5
):
1010
6
. .
42.
Travison
TG
,
Morley
JE
,
Araujo
AB
,
O’Donnell
AB
,
McKinlay
JB
.
The relationship between libido and testosterone levels in aging men
.
J Clin Endocrinol Metab
.
2006 Jul
;
91
(
7
):
2509
13
. .
43.
Wu
FC
,
Tajar
A
,
Beynon
JM
,
Pye
SR
,
Silman
AJ
,
Finn
JD
,
Identification of late-onset hypogonadism in middle-aged and elderly men
.
N Engl J Med
.
2010 Jul 8
;
363
(
2
):
123
35
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.